MORELLI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 575
EU - Europa 456
AS - Asia 74
AF - Africa 5
OC - Oceania 1
Totale 1.111
Nazione #
US - Stati Uniti d'America 555
IT - Italia 290
NL - Olanda 46
UA - Ucraina 44
CN - Cina 40
FI - Finlandia 21
CA - Canada 20
IE - Irlanda 16
DE - Germania 15
SE - Svezia 14
VN - Vietnam 14
TR - Turchia 10
CI - Costa d'Avorio 5
GB - Regno Unito 5
FR - Francia 4
IN - India 4
SG - Singapore 4
AU - Australia 1
CH - Svizzera 1
JP - Giappone 1
TW - Taiwan 1
Totale 1.111
Città #
Chandler 154
Napoli 74
Naples 50
Jacksonville 49
Amsterdam 46
Millbury 26
Princeton 21
Woodbridge 21
Ottawa 18
Ashburn 14
Boston 13
Dong Ket 12
Nanjing 12
Ann Arbor 11
Houston 11
Rome 9
Wilmington 9
Caserta 8
Jiaxing 8
Beijing 7
Dearborn 6
Des Moines 6
Barano d'Ischia 5
Cercola 5
Mugnano di Napoli 5
Salerno 5
Kronberg 4
Lawrence 4
Nanchang 4
Pune 3
Redwood City 3
Tianjin 3
Washington 3
Boardman 2
Calgary 2
Cambridge 2
Capodrise 2
Casoria 2
Fairfield 2
Falls Church 2
Formia 2
Ho Chi Minh City 2
Indiana 2
Kapolei 2
Menlo Park 2
Milan 2
Norwalk 2
Paris 2
Piombino 2
Romainville 2
Shenyang 2
Brisbane 1
Castelpagano 1
Cava De' Tirreni 1
Changsha 1
Gavirate 1
Guangzhou 1
Hyderabad 1
Jinan 1
Lanzhou 1
Lequile 1
Les Acacias 1
Messina 1
Mondolfo 1
Pomigliano D'arco 1
Pontecagnano 1
Seattle 1
Vallo della Lucania 1
Totale 682
Nome #
Synthesis, structural behaviors and biological properties of thrombin binding aptamers singly modified with chiral m-nitro-benzene glycidoyl moiety 83
Development and validation of an analytical method for total polyphenols quantification in extra virgin olive oils 78
Outstanding effects on antithrombin activity of modified TBA diastereomers containing an optically pure acyclic nucleotide analogue 69
Exploring the photodynamic properties of two antiproliferative benzodiazopyrrole derivatives 65
Antagonizing S1P3 receptor with cell-penetrating pepducins in skeletal muscle fibrosis 60
Effects of drug resistance mutations L100I and V106A on the binding of pyrrolobenzoxazepinone nonnucleoside inhibitors to the human immunodeficiency virus type 1 reverse transcriptase catalytic complex 57
Characterization of the 1H-Cyclopentapyrimidine-2,4(1H,3H)-dione Derivative (S)-CPW399 as a Novel, Potent, and Subtype-Selective AMPA Receptor Full Agonist with Partial Desensitization Properties 51
Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. 51
D-Galactose as a Vector for Prodrug Design. 51
Investigating the role of T7 and T12 residues on biological properties of Thrombin Binding Aptamer: enhancement of anticoagulant activity by a single nucleobase modification 51
Investigating the Role of T7 and T12 Residues on the Biological Properties of Thrombin-Binding Aptamer 51
Pyrrolobenzoxazepinone (PBO) Derivatives as Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further Structure-Activity Relationship Studies and Identification of More Potent Broad Spectrum HIV-1 RT Inhibitors with Antiviral Activity. 44
Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent 43
Synthesis, structural studies and biological properties of new TBA analogues containing an acyclic nucleotide 41
Non-nucleooside HIV-1 reverse transcriptase (RT) inhibitors : Past, present. And future perspectives. 36
Structural and biological studies on new TBA analogues: the role of TBA-quadruplex molecularity in the TBA-thrombin complex 36
Polycondensed heterocycles. Part 12: An approach to the synthesis of 2-acetyl-1'-methyl-1,2,3,4-tetrahydrospiro[isoquinoline-1,4'-pyrrolidine]-2'-one. 30
Development of potent and selective peripheral 5-HT3 receptor agonists and antagonists, keystones of a new therapeutic strategy to cardiac diseases 30
Inherent desensitization-preventing properties of a novel, subtype-selective AMPA receptor agonist, (S)-CPW 399, as a possible explanation for its excitotoxic action in cultured cerebellar granule cells. 29
Novel, Potent, and Selective Quinoxaline-Based 5-HT3 Receptor Ligands. 1: Further Structure-Activity Relationships and Pharmacological Characterization 29
Pyrroloquinoxaline Derivatives as a New Class of Potent and Selective 5-HT3 Receptor Agonists. Synthesis, Further Structure-Activity Relationhsips and Biological Studies. 29
Cis-trans photodynamics of benzodiazopyrrole derivatives in view of biomedical applications 28
1H-Cyclopentapyrimidine-2,4(1H,3H)-dione-Related Ionotropic Glutamate Receptors Ligands. Structure-Activity Relationships and Identification of Potent and Selective iGluR5 Modulators. 28
Synthesis of New Molecular Probes for Investigation of Steroid Biosynthesis Induced by Selective Interaction with Peripheral Type Benzodiazepine Receptors (PBR). 26
Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships. 23
Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Synthesis and Biological Evaluation of Novel Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Antiviral Agents. 22
Validation of an Eco-Friendly Automated Method for the Determination of Glucose and Fructose in Wines 18
Multi-Mycotoxin Analysis in Italian Grains Using Ultra-High-Performance Chromatography Coupled to Quadrupole Orbitrap Mass Spectrometry 6
Totale 1.165
Categoria #
all - tutte 3.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 0 0 6
2019/2020137 29 1 9 0 16 7 2 34 0 4 18 17
2020/2021182 13 9 11 15 14 15 11 4 13 2 63 12
2021/2022185 3 4 2 5 6 9 0 11 18 10 52 65
2022/2023342 33 34 13 30 42 32 14 30 41 47 24 2
2023/2024127 22 18 20 15 7 11 8 10 4 5 7 0
Totale 1.165